- Home
- AVTX vs VINP Comparison
AVTX vs VINP Comparison
Compare AVTX & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVTX | VINP |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 601.4M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AVTX | VINP |
|---|---|---|
| Price | $7.81 | $8.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $34.80 | $12.69 |
| AVG Volume (30 Days) | ★ 2.9M | 133.8K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 7.04% |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | $19.04 |
| Revenue Next Year | N/A | $11.35 |
| P/E Ratio | ★ N/A | $24.41 |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $6.53 | $8.40 |
| 52 Week High | $24.27 | $13.61 |
Technical Indicators
Market Signals| Indicator | AVTX | VINP |
|---|---|---|
| Relative Strength Index (RSI) | 38.51 | 39.28 |
| Support Level | $6.53 | $8.40 |
| Resistance Level | $20.54 | $10.17 |
| Average True Range (ATR) | 0.62 | 0.43 |
| MACD | 0.36 | -0.03 |
| Stochastic Oscillator | 62.35 | 50.16 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.